3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
3
Phase 4
3
Phase EARLY_PHASE1
1
Phase 3
1
Status
Terminated
1
Recruiting
1
Completed
1
Sponsor Class
INDUSTRY
3
Study Type
Interventional
3
Sponsor
Cancer Type
Gastrointestinal
2
NET
1
Genitourinary
1
Endocrine
1
CNS
1
Breast
1
Conditions
Carcinoma, Hepatocellular
2
Prostatic Neoplasms
1
Neuroendocrine Tumors
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Dexamethasone
56
Metformin
50
Cyclophosphamide
47
Saline Solution
39
Cytarabine
37
Cisplatin
37
Zoledronic Acid
34
Letrozole
34
Sodium Chloride
33
Carboplatin
33
Bupivacaine
31
Bevacizumab
31
Docetaxel
30
Vincristine
29
Methotrexate
29
Fluorouracil
28
Propofol
27
Capecitabine
27
Fentanyl
26
Doxorubicin
26
Rituximab
25
Drug Therapy
25
Dexmedetomidine
25
Prednisone
23
Paclitaxel
23
Gemcitabine
22
Oxaliplatin
21
Morphine
21
Radiotherapy
19
Prednisolone
19
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 4
×
Interventional
×
gadoterate meglumine
×
Clear all
NCT04373564
2026-01-22
ODYSSEY
Guerbet
Phase 4
Recruiting
2,076 enrolled
NCT01806740
2019-08-08
DCE-MRI
Guerbet
Phase 4
Terminated
37 enrolled
12 charts
NCT02034708
2016-12-30
REMIND
Guerbet
Phase 4
Completed
279 enrolled
9 charts